1 |
Marriot, J.B., Westby, M., Cookson, S., Guckian, M., Goodbourn, S., Muller, G. CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF- production. J Immunol, 161: 4236-4243, 1998.
|
2 |
Mathiak, G., G. Grass., T. Herzmann., T. Luebke., C. Cu-Zetina., S.A. Boehm. Capase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses.Br J Pharmacol, 131: 383-386, 2000.
DOI
ScienceOn
|
3 |
Eduard, F.M., S.M.R. Martha., P.A. Victor., M. Pablo. Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat. Biochemical pharmacology, 68: 1321-1329, 2004.
DOI
ScienceOn
|
4 |
Aono, K., K. Isobe., K. Kuichi., Z. Fan., M. Ito, A. Takeuchi. In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: involvement of other cytokines. J cell Biochem, 65: 349-358, 1997.
DOI
ScienceOn
|
5 |
Sang H., G.L. wallis, C.A. Stewart., K. Yashige. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch Biochem Biophys, 363: 341-348, 1999.
DOI
ScienceOn
|
6 |
Chao, C.Y., Yeh, S.L., Lin, M.T., Chen, W.J. Effects of parenteral infusion with fish-oil or safflower-oil emulsion on hepatic lipids, plasma amino acids, and inflammatory mediators in septic rats. Nutrition, 16: 284-288, 2000.
DOI
ScienceOn
|
7 |
Abul K., Andrew H Lichtman., Shiv Pillai. Cellular and molecular immunology. 6th edition. p 354, 2007.
|
8 |
Yun, H.J., Heo, S.K., Yi, H.S., Kim, C.H., Kim, B.W., Park, S.D. Anti-inflammatory effect of Injinho-tang in RAW 264.7 Cells. Kor. J. Herbology 23(2):169-178, 2008.
|
9 |
Rabson, A., Roitt, I.M., Delves, P.J. Really essential medical immunology. Blackwell publishing Ltd, Oxford. pp 1-14, 2005.
|
10 |
Boumpas, D.T., Chrousos, G.P., Wilder, R.L., Cupps, T.R., Balow. J.E. Glucocorticoid therapy of immune-mediated diseases: basic and clinical correlates. Ann Intern Med, 119: 1198-1208, 1993.
DOI
ScienceOn
|
11 |
Barton, C.C., E.X. Barton, P.E. Ganey, S.L. Kunkel, R.A. Roth. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor- . Hepatology, 33: 66-73, 2001.
DOI
ScienceOn
|
12 |
Surh, Y.J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 40(8):1091-1097, 2002.
DOI
ScienceOn
|
13 |
Seo, W.G., Pae, H.O., Oh, G.S., K.Y. Chai., Kwon, T.O., Yun, Y.G., Kim, N.Y., Chung, H.T. Inhibitory rotundus rhizomes on nitric oxide and superoxide production by murine macrophage cell line, Raw 264.7 cells. J Ethnopharmacol. 76: 59-64, 2001.
DOI
ScienceOn
|
14 |
김태희, 양기숙, 황은진, 박성배. 마황의 면역작용에 미치는 영향. 생약학회지 22(3):183-191, 1991.
|
15 |
김창민, 신민교, 이경순, 안덕균. 중약대사전, 도서출판정담, 서울, p 1718, 1998.
|
16 |
Lee E. Anti-inflammatory effect of Scutellariae Radix. Korean J. Plant Res. 20(6): 548-522, 2007.
|
17 |
남정연, 이현선, 이승웅, 정미연, 최정호, 유은숙, 노문철, 김영국. 감국에서 분리한 Kikkanol F Monoacetate와 5-Hydroxy-6,7,3',4'-tetramethoxy -flavone의 IL-6 생성억제활성. 생약학회지 36(3):186-190, 2005.
|
18 |
고인자, 유승조, 이은방. 한국산 하고초류의 약물학적 연구(1). 생약학회지 17(3):232-241, 1986.
|
19 |
약품식물학연구회. 신약품식물학. 서울, 학창사, p 336, 1996.
|
20 |
육창수. 원색한국약용식물도감. 서울, 아카데미서적, p 368, 1993.
|
21 |
최우회, 박웅양, 황방연, 오갑지, 강신정, 이경순, 노재섭. 말채나무수피의 페놀성 화합물. 생약학회지 29(3):217-224, 1998.
|
22 |
임채성, 이춘영, 김용무, 이위영, 이해익. 말채나무 추출물의 a-amylase 저해 활성. 한국응용생명화학회지 48(1):103-108, 2005.
|
23 |
Aggarwal, B.B., Kohr, W.J., Hass, P.E., Moffat, B., Spencer, S.A., Henzel, W.J., Bringman, T.S., Nedwin, G.E., Goeddol, D.V., Harkins, R.N. human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 260(4):2345-2354, 1985.
|
24 |
Delgado, A.V., McManus, A.T. Chambers JP. production of tumor necrosis factor-alpha, interleukin1-beta, interleukin 2, and interleukin 6, by rat leukocyte subpopulations after exposure to substance P. Neuropeptides. 37(6):355-361, 2003.
DOI
ScienceOn
|
25 |
Hibi, M., Nakajima, K., Hirano, T. IL-6 cytokine family and signal transduction: amodel of the cytokine system. J Mol Med. 4(1):1-12, 1996.
|
26 |
Yoon, H.J., Moon, M.E., Park, H.S., Im, S.Y., Lee, J.H., Kim, Y.H. Researck Papers : Effects of Chitosanoligosaccharide on the C.albicans-induced Inflammatory Effect in Mice and RAW264.7 Macrophage cells. J. Chitin Chitosan. 12(1):15-20, 2007.
|
27 |
Bacci, S., Pieri, L., Buccoliero, A.M., Bonelli, A., Taddei, G., romagnoli, P. Smooth muscle cells, dendritic cells and mast cells are sources of TNFalpha and nitric oxide in human carotid artery atherosclerosis. Thromb Res. 122(5):657-667, 2008.
DOI
ScienceOn
|
28 |
Vilcek, J., Lee, T.H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 266(12):7313-7316, 1991.
|
29 |
Hamada, E., Nishida, T., Uchiyama, Y., Nakamura, J., Isihara, K., Kazuo, H. Activation of Kupffer cells and caspases-3 involved in rat hepatocyte apoptosis induced by endotoxin. J. Hepatol, 30: 807-818, 1999.
DOI
ScienceOn
|
30 |
Pender, S.L., Breese, E.J., Gϋnther, U. Suppression of T-cell-mediated injury in human gut by interleukin 10: Role of matrix metalloproteinases. Gastroenterology. 115: 573-583, 1999.
|
31 |
Clerici, M., Ferrario, E., Trabattoni, D., Viviani, S., Bonfganti, V., Vanzon, D.J. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur. J. Cancer. 30A: 1464-1470, 1994.
|
32 |
Kakuma, S., Fukatsu, A., Shinagawa, T., Kurokawa, S., Kusakabe, A. Localization of intra hepatic interleukin-6 in patients with acute and chronic liver disease. J Clin Pathol 45: 408-411, 1992.
DOI
|
33 |
Busam, K.J., Bauer, T.M., Bauer, J., Gerok, W., Decker, K. Interleukin-6 release by rat liver macrophages. J Hepatol 11: 367-373, 1990.
DOI
ScienceOn
|
34 |
Jirik, F.R., Podor, T.J., Hirano, T. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142: 144-147, 1989.
|
35 |
Sehgal, P.B., Helfgott, D.C., Santhaanam. Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta2-interferon/hepatocyte -stimulating factor/interleukin6 gene in virus-infected human fibroblasts. J Exp Med 167: 1951-1956, 1988.
DOI
ScienceOn
|
36 |
Frei, K., Malipiero, U.V., Leist, T.P., Zinkernagel, R.M., Sehwab, M.E., Fontana, A. On the cellular source and function of interleukin 6 production in the central nervous system in viral disease. Eur J Immunol 19: 689-694, 1989.
DOI
ScienceOn
|
37 |
Beutler, B.B., Greenwald, J.D., Hulmes, M., Chang, Y.C., Pan, J., Maathison. et al. Identity of tumor necrosis factor and the macrophage secreted factor cachectin. Nature, 316: 552-556, 1985.
DOI
ScienceOn
|
38 |
Louis, H.O., LeMoine, M.O., Peny, E., Quertinmont, D., Fokan, M., Goldman. et al. Production and role of interleukin-10 in concanavalin A- induced hepatitis in mice. Hepatology, 25: 1382-1389, 1997.
DOI
ScienceOn
|
39 |
Thompson, K.C., A, Trowern., A, Fowell., M, Marathe., C, Haycock., M.J.P. Arthur et al. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology, 28: 1518-1524, 1998.
DOI
ScienceOn
|